Skip to main content
. Author manuscript; available in PMC: 2017 Nov 20.
Published in final edited form as: Clin Cancer Res. 2017 Jan 12;23(6):1422–1431. doi: 10.1158/1078-0432.CCR-16-1153

Figure 2.

Figure 2

A, Discrimination between EBC patients without relapse for at least 6 years (black circles, n =85) and MBC patients (gray squares, n =109) using the RF classifier on CPMG spectra. The confusion matrix is also reported. B, Prediction of relapse in the test set containing 192 EBC with relapse and 42 EBC without relapse up to 6 years. The ROC and AUC scores are presented for the RF risk score on CPMG spectra. The confusion matrix is also reported.